Table 3. Pointers for identifying fraudulent/erroneous systematic reviews.
| 1. Systematic reviews and meta-analyses on observational data, especially genetic polymorphisms, should be looked at more carefully |
| 2. Reviews on healthcare outcomes are not registered at PROSPERO |
| 3. No PRISMA diagram and a broad literature search |
| 4. Literature search and data extraction are not done independently by at least two reviewers |
| 5. Lack of assessment of heterogeneity of primary studies |
| 6. No risk of bias or assessment of study quality performed |
| 7. A similar reviews is published recently (with 2 years), unless a major change in therapeutics or new evidence have emerged |
| 8. Undeclared commercial editing and writing support/brokering |
PROSPERO = International Prospective Register of Systematic Reviews, PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses.